Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cheaper stents vs. pricier ones: which is better value for liver patients?

NCT ID NCT00593528

First seen Jan 06, 2026 · Last updated Jun 16, 2026 · Updated 31 times

Summary

This study looked at two types of stents used in a procedure called TIPS, which creates a bypass in the liver to relieve complications of cirrhosis. One stent is covered with a special material to stay open longer but costs more; the other is a standard bare stent that is cheaper but may need more follow-up procedures. Researchers compared how well each stent worked and their overall cost-effectiveness in 138 patients with liver cirrhosis.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CIRRHOTIC PORTAL HYPERTENSION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • AP-HM / La Conception

    Marseille, 13003, France

  • AP-HM / La Timone

    Marseille, 13385, France

  • Ap-Hp (Paul Brousse)

    Villejuif, 94804, France

  • CHRU NANTES / Hôpital Guillaume et René Laënnec

    Nantes, 44800, France

  • CHRU NANTES / Hôtel-Dieu

    Nantes, 44093, France

  • CHRU de TOURS

    Tours, 37044, France

  • Chru Bordeaux

    Bordeaux, 33075, France

  • Chru Caen

    Caen, 14033, France

  • Chru Clermont Ferrand

    Clermont-Ferrand, 63058, France

  • Chru Dijon

    Dijon, 21079, France

  • Chru Nice

    Nice, 06202, France

  • Chru Poitiers

    Poitiers, 86021, France

Conditions

The condition(s) this trial relates to.

Fibrosis portal hypertension

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.